Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

MAIL-ORDER PHARMACY GMP REGULATION BY FDA

Executive Summary

MAIL-ORDER PHARMACY GMP REGULATION BY FDA was urged by Ferdic Inc. in an Oct. 21 citizen petition. Agency field investigators should inspect for compliance with Good Manufacturing Practices "all corporate facilities that dispense, package, and introduce into interstate commerce finished prescription drug products in the form of mail-order prescriptions for individual use pursuant to a" prescription, the company said. Ferdic is a news organization specializing in pharmacy and FDA topics. It's publications include "Dickinson's Pharmacy" and "Dickinson's FDA." The Ferdic petition contends that state pharmacy boards and local authorities, the traditional regulators of mail order pharmacies, "lack adequate financial resources and effective jurisdictional reach to police this interstate business." Furthermore, Ferdic argued, "unless FDA voluntarily and preemptively asserts its statutory federal jurisdiction over the industry, many more deaths from drug mix-ups will occur, some of these deaths will be publicly associated with the drugs involved, and the ensuing controversy may hurt the public esteem and trust that FDA has long enjoyed." Because there are fewer than "20 mail-order pharmacies large enough to warrant routine FDA inspection," the company continued, "the added burden of biennial inspections on agency field resources would be slight."
Advertisement
Advertisement
UsernamePublicRestriction

Register

PS014611

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel